Book your Virtual Summit pass at £245
BOOK NOW

Innovative solutions to the greatest challenges in pharmaceutical development

15th – 17th March 2021

The 2021 Virtual Summit covers both small molecules and biologicsnew technologies, concepts and case studies in areas such as:

  • Formulation design for poorly soluble compounds
  • The potential of nanotechnology for better deliverability
  • The latest controlled released technologies
  • Improving patient compliance by harnessing data and the latest smart device technology
  • Optimising formulations for continuous manufacturing
  • Overcoming the blood brain barrier and challenges in oral delivery of biologics
  • Reformulation and biosimilars

2021 Speakers

Andrea Benassi

Chiesi

CMC – Chemistry Manufacturing & Controls, Drug Product manufacturing & Innovation, New Technology & Innovation Scientist

Dr. Fatima Bennai-Sanfourche

Bayer

Director Medical device Safety, Medical Device Safety Officer

Beate Bittner

Roche

Product Optimization Franchise Leader

Jace Blackburn

Genentech

Smart Device Engineer

Jeffrey T. Blue

MSD

Executive Director, Vaccine Drug Product Development PR&D

Erwan Bourles

GSK

Senior Manager, Head of Drying and Related Modelling Technologies Drug Product development Unit

Dr. Stefan Bracht

Bayer

Vice President Head of Disruptive Technologies

Olivier Brass

Sanofi

Senior scientist, lead of research unit, research department

Scott Brown

MSD

Devices Director

Camilla Foged

University of Copenhagen

Professor Vaccine Design and Delivery Group

David Cipolla

Insmed Inc.

Vice President of Research

Matthew Clemente

Novo Nordisk

Vice President, Device Development, Device R&D

Tejal Desai

UCSF

Professor

Ranjit Dhenge

GlaxoSmithKline

Investigator R&D

Ryan F. Donnelly

Queen's University Belfast

Chair in Pharmaceutical Technology

Sachin Dubey

Ichnos Sciences SA

Senior Associate Director, Drug product and Analytical Development

Gabriele Sadowski

TU Dortmund

Professor for Thermodynamics

Patrick Garidel

Boehringer Ingelheim

Head of Process, Purification and Pharma Development

Rob Gelissen

W. L. Gore & Associates – PharmBIO Division

Business Development for Drug Delivery and Packaging

Mark Guarraia

Novo Nordisk

Vice President, Design and User Experience

Heinrich Haas

BioNTech

Vice President, Formulation

Robert Hennig

Merck

Associate Director Drug Delivery & Innovation, Healthcare R&D

Korinde van den Heuvel

DFE pharma

Senior Product Developer

Shiqi Hong

Roquette

Senior biopharma scientist

Kristiina M. Huttunen

University of Eastern Finland

Adjunct Professor (Docent) and Finnish Academy Research Fellow

Lynne Isopi

Merck

Scientist

Lynne A. Isopi

MSD

Principal Scientist, Vaccine Drug Product Development

Nitin Joshi

Harvard Medical School

Instructor of Anesthesia, Center for Nanomedicine

Karsten Fluegel

Merck

Postdoctoral Researcher | Drug Delivery & Innovation

Naila El Kechai

Sanofi

Formulation and Drug Product Team Leader

Claus-Michael Lehr

Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)

Head, Dept. of Drug Delivery (DDEL)

Philippe Lienard

Sanofi

Pre-Development Science Leader

Rosario LoBrutto

Sandoz

Head of Scientific Affairs

Dr. Christian Lotz

Pfanstiehl GmbH

General Manager EMEA

Dan Lund

Halo Labs

Director of Sales

Kenneth J. Mandell

LayerBio

Founder and CEO

Fadee Mondalek

Bayer

Head of internal development

Anette Müllertz

University of Copenhagen

Professor, Head of Center

Vishal Nashine

Janssen

Associate Director

Celine Ollier

Sanofi

PK-Biopharm Marketed Compounds

Rick Panicucci

QED Therapeutics

Senior Vice President CMC

Carolin Riehl

Merck

Principal Scientist | Lab Head Drug Delivery & Innovation

Dr Ana L Gomes dos Santos

AstraZeneca

Principal Scientist

Luis Santos

AstraZeneca

Drug Delivery Leader, Biopharmaceutical Development, Cell and Gene Therapies, Innovation

Stefan Schneid

Bayer

Laboratory Head Formulation Development Parenterals

Aaron Stewart

Lonza

Associate Principal Scientist

Dr. Timo Taghizadeh

tesa Labtec GmbH

Head of Business Development & Marketing

Vivek Trivedi

University of Kent

Lecturer in Drug Delivery, Medway School of Pharmacy

Ijeoma F. Uchegbu

University College London

Chair in Pharmaceutical Nanoscience

Bharathi Vellalore

Janssen

Scientist, Drug Product Development Discovery, Product Development and Supply

Kerstin Walke

Boehringer Ingelheim

Head of Pharmaceutical Development Biologicals

Latest News

Silicones for drug infusion devices - From hospital to wearable: how silicones are used at different scales to help patients live a normal life

This e-book presents an overview of the medical, industrial, compliance and economic advantages and challenges in the use of silicone materials in Infusion as a method of drug delivery. The unique properties of silicones along with their longstanding, proven track record in medical applications, can enable innovative solutions that improve the quality and efficacy of infusion care.

PMC Isochem To accelerate Polyamino acids Business as part of ISODEL® Drug Delivery offer, a unique One Stop Shop for NCA and PAA

PMC Isochem announces today that it is accelerating the strategic development and manufacture of polyamino acids (PAA) as functional excipients used in complex formulations and drug delivery solutions. Based on its own internal resources and endowed with a fully integrated know-how as well as its leading position in the manufacture of critical Activated Amino Acids (NCA), PMC Isochem becomes the reliable supplier of PAA and the sustainable partner.

Upperton Invest £500K in their Tablet Formulation and Manufacturing Capabilities

Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO) have invested £500K in significantly expanding their tablet manufacturing capabilities with the addition of tablet processing equipment for wet granulation, roller compaction, tablet compression, hardness testing, dedusting, weight sorting and tablet coating throughout 2019 and 2020. This investment of £500K will enhance the company’s development and manufacturing capabilities whilst strengthening their ability to support clients’ research, development and clinical manufacturing needs.
×